Everything we know about Mounjaro, new NHS weight loss jab

Fast-growing drugmaker Eli Lilly and Co. would consider Wisconsin sites for new plants beyond a $3 billion project the ...
Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some ...
Mounjaro is a treatment for Type 2 diabetes that activates GIP and GLP-1 pathways to help regulate blood sugar. It’s part of ...
Eli Lilly's weight-loss jab Mounjaro has been cleared for rollout by the NHS in England, with around 3.4 million people ...
Following its endorsement of Eli Lilly’s obesity medicine tirzepatide, England’s National Institute for Health and Care ...
The Mounjaro jab has been branded the “King Kong of weight-loss drugs” and could offer life-changing support for people in ...
Tirzepatide, available as Mounjaro, has been hailed as the 'King Kong' of slimming jabs and a breakthrough in the war on obesity — more effective for shifting the pounds than similar drugs like ...
The expansion of a newly acquired facility in Wisconsin is Lilly’s largest U.S. manufacturing investment outside of Indiana ...